Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel and Cisplatin in Advanced or Recurrent Endometrial Cancer
NCT01461759Phase 2Unknown
- Sponsor
- Asan Medical Center
- Start
- Oct 2011
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel in endometrial cancer (EC), sponsored by Asan Medical Center. Status: unknown.
02
Drugs
docetaxel
03
Conditions
endometrial cancer (EC)
Beyond the preview
Go deeper on NCT01461759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01461759.